💨 Abstract

Xenon Pharmaceuticals reported a first-quarter loss of $65 million, or 83 cents per share, which exceeded Wall Street's expectations of a 94 cents per share loss. The company's revenue for the period was $7.5 million, matching analysts' forecasts.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖